# DEFLAGYN® Vaginal Gel and Spontaneous Remission and Regression of Unclear Cervical Smears and HPV High-risk Infections

> **NCT05509413** · NA · COMPLETED · sponsor: **Ruhr University of Bochum** · enrollment: 242 (actual)

## Conditions studied

- Cervix Dysplasia
- HPV Infection

## Interventions

- **DEVICE:** DEFLAGYN vaginal gel

## Key facts

- **NCT ID:** NCT05509413
- **Lead sponsor:** Ruhr University of Bochum
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-11-08
- **Primary completion:** 2025-05-23
- **Final completion:** 2025-08-28
- **Target enrollment:** 242 (ACTUAL)
- **Last updated:** 2025-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05509413

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05509413, "DEFLAGYN® Vaginal Gel and Spontaneous Remission and Regression of Unclear Cervical Smears and HPV High-risk Infections". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05509413. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*